Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

Conditions: Hepatocellular Carcinoma Interventions: Drug: TKI+Cardunilimab Sponsors: Peking Union Medical College Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials